Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese HSK 1 – For Medical Students & Physicians A complete 20-lesson, 300-page Chinese HSK 1 course with a companion app in 21 languages — free forever. Arabic, Bengali, Dutch, English, Farsi, French, German, Hindi, Indonesian, Italian, Japanese, Korean, Portuguese, Russian, Spanish, Tagalog, Thai, Turkish, Ukrainian, Urdu, Vietnamese. By Bernd Sebastian Kamps and Andrea Melis

Parkinson's Disease

Free Subscription 13.04.2026 1 BMC Neurol 1 Exp Brain Res 1 Exp Neurol 3 J Neural Transm (Vienna) 2 Mov Disord 1 Nat Neurosci 2 Neurobiol Dis 1 Neurol Clin Pract 1 Neurology 1 Neurosci Lett 1 Neuroscience 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Neurol

1. CHEN K, Xu B, Ji Y, Hao W, et al
   Association between iron deposition and emotional disorder in Parkinson's patients: a systematic review and meta-analysis.
   BMC Neurol. 2026 Apr 6. doi: 10.1186/s12883-026-04866.
   PubMed        
   
   

   
   Exp Brain Res

2. READMAN MR, Giebel C, Cannon J, Fairman I, et al
   Parkinson's disease dementia and hearing impairment, are they related? A UK biobank pilot analysis.
   Exp Brain Res. 2026;244:85.
   PubMed        
   
   

   
   Exp Neurol

3. SHEN Z, Garland B, Mellick GD, Ma L, et al
   A refined chronic MPTP/probenecid model of Parkinson's disease in mature adult mice.
   Exp Neurol. 2026 Apr 4:115759. doi: 10.1016/j.expneurol.2026.115759.
   PubMed         Abstract available
   
   

   
   J Neural Transm (Vienna)

4. REYES NGD, Pajo AT, Saranza G, Hoglinger GU, et al
   Correction: Revisiting Parkinson's disease definition and classification: insights from two emerging biological frameworks.
   J Neural Transm (Vienna). 2026 Apr 6. doi: 10.1007/s00702-026-03135.
   PubMed        
   
   
5. KANOVSKY P, Mensikova K, Cupr P, Vodicka R, et al
   Genetic and environmental risk factors of Parkinsonism.
   J Neural Transm (Vienna). 2026 Apr 6. doi: 10.1007/s00702-025-03058.
   PubMed         Abstract available
   
   
6. ROBINSON MJ, Chou KL, Schmitt TR, Patil PG, et al
   N-of-1 tissue activation modeling reveals regional subthalamic stimulation predicting verbal fluency decline in Parkinson disease.
   J Neural Transm (Vienna). 2026 Apr 6. doi: 10.1007/s00702-026-03150.
   PubMed        
   
   

   
   Mov Disord

7. BANJAW Z, Assefa Z, Bogaert E, Crosiers D, et al
   Genetic Landscape of Monogenic Parkinson's Disease in the African Population-A Systematic Review.
   Mov Disord. 2026 Apr 9. doi: 10.1002/mds.70302.
   PubMed         Abstract available
   
   
8. MUNIR I, Noor G, Soomro MI
   Neurogenesis as a Biomarker of Disease Modification in Parkinson's Disease.
   Mov Disord. 2026 Apr 5. doi: 10.1002/mds.70312.
   PubMed        
   
   

   
   Nat Neurosci

9. HOWELLS H
   A network signature of Parkinson's disease.
   Nat Neurosci. 2026;29:772.
   PubMed        
   
   

   
   Neurobiol Dis

10. HE Y, Kaya I, Zhang X, Nilsson A, et al
    Spatial lipidomics identifies alpha-synuclein-induced lipid changes in an AAV-induced Parkinsonian mouse model.
    Neurobiol Dis. 2026;223:107372.
    PubMed         Abstract available
    
    
11. D'ADDARIO SL, Cenere MM, Cossa F, Scaricamazza S, et al
    Effects of neuromelanin buildup in rodent nigral dopamine neurons: implications for sex-biased vulnerability in Parkinson's disease.
    Neurobiol Dis. 2026;223:107378.
    PubMed         Abstract available
    
    

    
    Neurol Clin Pract

12. KRENING E, Shuman R, Faouzi M, Thai K, et al
    Feasibility for a Community-Based Parkinson Disease Cohort in Hawaii.
    Neurol Clin Pract. 2026;16:e200603.
    PubMed         Abstract available
    
    

    
    Neurology

13. DEL PAPA DF, Herman J, Kunju AT, Najafi T, et al
    Neurovascular Unit Dysfunction and Cerebral Small Vessel Disease in Parkinson Disease: A Systematic Review and a Meta Analysis.
    Neurology. 2026;106:e214873.
    PubMed         Abstract available
    
    

    
    Neurosci Lett

14. SARUKHANYAN F, Hunanyan O, Zakaryan H, Knaryan V, et al
    Hemorphin LVV-H3 attenuates calcineurin activity and regulates cytokine levels in experimental Parkinson's disease.
    Neurosci Lett. 2026;879:138598.
    PubMed         Abstract available
    
    

    
    Neuroscience

15. BIZET B, Trinchi M, Nardello F, Bombieri F, et al
    Quantitative ultrasound radiofrequency analysis for monitoring Parkinson's disease.
    Neuroscience. 2026 Apr 7:S0306-4522(26)00254.
    PubMed         Abstract available
    
    

    
    PLoS One

16. ASGHAR A, Chohan TA, Qayyum A, Rana SM, et al
    Correction: Unveiling the biochemical potential of Acacia jacquemontii as a therapeutic agent in parkinson's disease: A multi-model in Vitro, In Vivo, and In Silico Study.
    PLoS One. 2026;21:e0346807.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum